Major pharmaceutical companies are driving innovation and competing in the non-metastatic prostate cancer market.

The entities involved

• Pfizer →

  American multinational pharmaceutical and biotechnology corporation

  • Pfizer filed with the SEC on May 27, 2026, regarding institutional share holdings and active buying/selling of stock.Tue 14:20
  • Verizon's Frontier deal increased debt, while Kraft Heinz and Pfizer stock traded on Nasdaq.Mon 13:09
• AstraZeneca →

  British-Swedish pharmaceutical company

  • Analyst reports are driving stock market sentiment for Ballard Power Systems, AstraZeneca, Amgen, and Amazon.14:51
  • Dan Janiak joined OncoC4 as Chief Business Officer, having previously served at AstraZeneca.Mon 13:33
• Johnson & Johnson →

  U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer

  • Microsoft and Alphabet are funding the AI boom, while TRACE pricing data is used for bond comparisons and both companies hold AAA ratings.Tue 09:15
  • Gardiner Harris's investigative reporting led to fraud fines against Bristol-Myers Squibb and a book dissecting Johnson & Johnson scandals.Tue 01:35

Related events

• Pfizer, J&J, BMS, Sanofi, and AbbVie are leading innovation in personalized therapies and are key players in the multiple myeloma treatment market.Jun 7